Our findings indicate that inhibiting PLCγ1 suppresses human gastric adenocarcinoma growth and metastasis and that the signaling molecules Akt, ERK, Bad and S6 are all involved. This evidence concerns the gene PLCG1 and gastric adenocarcinoma.